About LieffCabraser

"One of the nation's premier plaintiffs firms," Lieff Cabraser has 120 lawyers in San Francisco, New York, Nashville, and Munich. We have a widely diversified practice successfully representing plaintiffs in the fields of personal injury and mass torts, securities and financial fraud, employment discrimination and unlawful employment practices, product defect, consumer protection, antitrust, environmental and toxic exposures, False Claims Act, digital privacy and data security, and civil and human rights. Our clients include individuals, classes and groups of people, businesses, and public and private entities.

Lieff Cabraser Duke/UNC “No Poach” Case Team to Receive Antitrust Institute’s 2019 Private Enforcement Award

The American Antitrust Institute has announced its selection of leading legal practitioners and economists to be recognized as honorees for the 2019 Antitrust Enforcement Awards, a list that includes the Lieff Cabraser team that worked on the Duke/UNC case: Dean M. Harvey, Kelly M. Dermody, Brendan P. Glackin, and Anne B.

2022-09-21T17:46:06+00:00October 15th, 2019|Antitrust, Awards, Firm News|

Mark Chalos to Discuss Guidelines for Representing Sexual Abuse Survivors at Upcoming “Mass Torts Made Perfect” Fall 2019 Conference

Lieff Cabraser partner Mark P. Chalos will participate in a panel discussion entitled: “What You Need to Know About Representing Sexual Abuse Survivors” at the “Mass Torts Made Perfect (MTMP) Conference,” on Thursday, October 24, 2019 at The Bellagio Hotel in Las Vegas. MTMP conferences are designed for individuals working in the area of plaintiff mass torts

2019-10-11T15:18:36+00:00October 11th, 2019|Firm News|

Only 2 Weeks Left for 2017 and 2018 Northern California Wildfire Victims to File Claims Against PG&E

An estimated 70,000 Wildfire Victim Claims Still Unfiled with October 21 Rapidly Deadline Approaching The claim filing deadline for victims of wildfires caused by PG&E power lines in 2017 and 2018 is quickly approaching. As reported by the New York Times, as many as 70,000 victims eligible for compensation may receive nothing if they do

2019-10-07T12:30:15+00:00October 7th, 2019|Fires & Burn Injuries|

Lieff Cabraser Files Multiple Teen Injury Lawsuits Against JUUL Over Stroke, Lung Collapse, and Seizure Related to E-Cigarette Use

Three new separate Juul lawsuits filed in California state court advance claims for injuries, design defects, strict products liability, negligence, fraudulent concealment, among other claims September 30, 2019—(SAN FRANCISCO)—The national plaintiffs’ law firm of Lieff Cabraser Heimann & Bernstein, LLP announces the filing of three separate injury and fraud lawsuits on behalf of teenagers from

2019-09-30T09:21:34+00:00September 30th, 2019|Personal Injury|

Final Approval Granted to $54.5m Duke/UNC “No Poach” Antitrust Case Settlement

On September 24, 2019, the U.S. District Court Judge Catherine C. Eagles granted final approval to the proposed settlement of the Duke/UNC “No Poach” case valued at $54.5 million. The settlement includes an unprecedented role for the United States Department of Justice to monitor and enforce extensive injunctive relief. Assistant Attorney General Delrahim remarked: “Permitting the

2019-09-29T12:33:20+00:00September 29th, 2019|Antitrust|

Lieff Cabraser Honored by National Law Journal with 2019 “Elite Trial Lawyers” Awards for Consumer Protection and Privacy/Data Breach

The National Law Journal (NLJ) has selected Lieff Cabraser for its 2019 “Elite Trial Lawyers” awards in the categories of Consumer Protection and Privacy/Data Breach. The award recognizes lawyers and law firms that have “demonstrated repeated success in cutting-edge work on behalf of plaintiffs over the last 18 months, along with a longer track record

2019-09-27T12:48:18+00:00September 27th, 2019|Awards, Consumer Fraud, Firm News|

Lieff Cabraser Named Class Counsel in Now-Certified Lovenox Antitrust Class Action Against Momenta & Sandoz

Case alleges Momenta and Sandoz conspired to monopolize the production and distribution of enoxaparin, a generic version of the blood clot drug Lovenox As reported by Law360, Chief Judge Waverly D. Crenshaw, Jr. of the United States District Court for the Middle District of Tennessee has certified a class of thousands of buyers of generic

2019-09-20T19:41:40+00:00September 20th, 2019|Antitrust|